Geographic accessibility to clinical trials for advanced cancer in the United States

JAMA Intern Med. 2015 Feb;175(2):293-5. doi: 10.1001/jamainternmed.2014.6300.

Authors

Matthew D Galsky¹, Kristian D Stensland¹, Russell B McBride², Asma Latif¹, Erin Moshier¹, William K Oh¹, Juan Wisnivesky³

Affiliations

¹ Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, New York, New York.
² Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Divisions of General Internal Medicine and Pulmonary and Critical Care, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 25437434
DOI: 10.1001/jamainternmed.2014.6300

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Clinical Trials as Topic*
Health Services Accessibility*
Humans
Neoplasms / therapy*
United States